adenosine diphosphate has been researched along with cp 320626 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ercan-Fang, N; Gannon, MC; Genereux, PE; Gibbs, EM; Kwon, Y; Levy, CB; Nuttall, FQ; Rath, VL; Taylor, MR; Treadway, JL | 1 |
| Gregus, Z; Németi, B | 1 |
2 other study(ies) available for adenosine diphosphate and cp 320626
| Article | Year |
|---|---|
Endogenous effectors of human liver glycogen phosphorylase modulate effects of indole-site inhibitors.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Amides; Animals; Blood Glucose; Cell Line; Dose-Response Relationship, Drug; Enzyme Activation; Fructosephosphates; Glucosephosphates; Glycogen; Humans; Hyperglycemia; Hypoglycemia; Indoles; Liver; Male; Phosphorylase a; Phosphorylase b; Rats; Rats, Sprague-Dawley; Uridine Diphosphate Glucose | 2005 |
Glutathione-dependent reduction of arsenate by glycogen phosphorylase responsiveness to endogenous and xenobiotic inhibitors.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Amides; Animals; Arabinose; Arsenates; Arsenites; Caffeine; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Enzyme Inhibitors; Glucose; Glucose-6-Phosphate; Glutathione; Glycogen; Glycogen Phosphorylase, Liver Form; Glycogen Phosphorylase, Muscle Form; Glycogenolysis; Imino Furanoses; Indoles; Male; Oxidation-Reduction; Quercetin; Quinolinic Acids; Rabbits; Rats; Rats, Wistar; Spectrometry, Fluorescence; Spectrophotometry, Atomic; Sugar Alcohols; Sulfhydryl Reagents; Xenobiotics | 2007 |